SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026996
Filing Date
2021-05-12
Accepted
2021-05-12 16:11:07
Documents
42
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20210331.htm 10-Q 804250
2 EX-31.1 evok-ex311_6.htm EX-31.1 9578
3 EX-31.2 evok-ex312_10.htm EX-31.2 9863
4 EX-32.1 evok-ex321_12.htm EX-32.1 5032
5 EX-32.2 evok-ex322_9.htm EX-32.2 5248
6 GRAPHIC gmyeixoxypmh000001.jpg GRAPHIC 44016
  Complete submission text file 0001564590-21-026996.txt   2619992

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT evok-20210331.xml EX-101.INS 326561
8 XBRL TAXONOMY EXTENSION SCHEMA evok-20210331.xsd EX-101.SCH 30128
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20210331_cal.xml EX-101.CAL 24245
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20210331_def.xml EX-101.DEF 80454
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20210331_lab.xml EX-101.LAB 217212
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20210331_pre.xml EX-101.PRE 159788
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 21915188
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences